Showing 1321-1330 of 2050 results for "".
- Revance’s DaxibotulinumtoxinA for Injection Looks Good in Phase 2 Studies of Forehead Lines and Crow’s Feethttps://modernaesthetics.com/news/revances-daxibotulinumtoxina-for-injection-looks-good-in-phase-2-studies-of-forehead-lines-and-crows-feet/2472963/Revance Therapeutics, Inc.’s next-generation neuromodulator product, DaxibotulinumtoxinA, safely and effectively smoothed forehead lines and Crow’s feet with a median duration of 27 weeks in forehead lines and 24 weeks in crow’s feet achieved in at least one treatment group
- CE Mark Plus Launch for System ONE-M from TOOsonix A/Shttps://modernaesthetics.com/news/ce-mark-plus-launch-for-system-one-m-from-toosonix-as/2472959/TOOsonix A/S is launching its CE-marked System ONE-M for color-independent tattoo removal, solar lentigines, spider veins, angiomas, telangiectasia and other aesthetic conditions. System ONE-M is a focused ultr
- Industry Vet Didier Leclercq Joins Aerolase Leadership Teamhttps://modernaesthetics.com/news/industry-vet-didier-leclercq-joins-aerolase-leadership-team/2472958/Didier Leclercq is Aerolase’s new Vice President of Global Market Development. Prior to his role as Managing Director of the SHIELD innovation center of Nestlé Skin Health/Galderma, Mr. Leclercq ran Q-Med onc
- Candela’s CO2RE Laser Platform Scores Health Canada Approval for Two New Gynecological Indicationshttps://modernaesthetics.com/news/candelas-co2re-laser-platform-scores-health-canada-approval-for-two-new-gynecological-indications/2472955/Health Canada has approved Candela’s CO2RE laser for the treatment of genitourinary syndrome of menopause (GSM) and stress urinary incontinence (SUI) in adult women. The CO2RE laser, a sing
- ISHRS Survey: Brad Pitt, Eva Longoria Top List of Most-Desired Celebrity Lockshttps://modernaesthetics.com/news/brad-pitt-eva-longoria-top-list-of-most-desired-best-celebrity-locks/2472949/When it comes to celebrity hair, it’s Brad Pitt and Eva Longoria’s locks that are most admired, according to a
- New Officers Announced at American Society for Laser Medicine and Surgeryhttps://modernaesthetics.com/news/new-officers-announced-at-american-society-for-laser-medicine-and-surgery/2472943/Thomas E. Rohrer, MD was introduced as President of the American Society for Laser Medicine and Surgery (ASLMS) during the Board of Directors meeting on April 30, 2020. ASLMS is the world's largest professional organization dedicated to promoting research, education, and high standards of cli
- Dr. Luis Rios Jr. Named New ASERF Presidenthttps://modernaesthetics.com/news/luis-rios-jr-md-named-new-aserf-president/2472935/Luis Rios Jr., MD, a plastic surgeon practicing in Edinburg, Texas, is the new president of The Aesthetic Surgery Education and Research Foundation (ASERF), the philanthropic research and education arm of The Aesthetic Society. As President, Dr. Rios will employ newly develo
- Galderma's Restylane Kysse FDA Approved for Lip Augmentation and Upper Perioral Rhytidshttps://modernaesthetics.com/news/galdermas-restylane-kysse-fda-approved-for-lip-augmentation-and-upper-perioral-rhytids/2472927/The FDA recently approved Galderma'a Restylane Kysse for lip augmentation and the correction of upper perioral rhytids in adults over the age of 21. Restylane Kysse is the first hyaluronic acid (HA) filler specifically indicated for the lips using XpresHAn Technology globally referred to as t
- Lumenis Virtual Conference 2020 Starts Tomorrowhttps://modernaesthetics.com/news/lumenis-virtual-conference-2020-starts-tomorrow/2472918/Those interested in learning more about the latest laser and RF technologies, seeking treatment tips, or looking to network with other practitioners may be interested in the Lumenis Virtual Conference 2020. The conference kicks off Thursday, April 23 and Friday, April 24 with live
- David Long Tapped As Cynosure's Global Chief Financial Officerhttps://modernaesthetics.com/news/david-long-is-cynosures-global-chief-financial-officer/2472908/David Long is Cynosure’s new Chief Financial Officer, effective immediately. Until recently, Long served as CFO at Corindus Vascular Robotics, Inc., where he brought the company public and, ultimately, navigated its